Clinical Trial Update: Use of NGAL for Fluid Dosing and CRRT Initiation in Pediatric and Neonatal AKI [NA]

View source ↗

Summary

The clinical trial evaluating NGAL for guiding fluid dosing and initiation of CRRT in pediatric and neonatal acute kidney injury has been withdrawn. The study w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Injury
• Kidney Injury Due to Sepsis
• Neonatal Sepsis

Snippet

Sponsor: Children's Hospital Medical Center, Cincinnati | Conditions: Acute Kidney Injury, Acute Kidney Injury Due to Sepsis | NA | Status: WITHDRAWN